NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer

Clinical trial NCT05773859 · RECRUITING

Trial details

NCT number: NCT05773859
Sponsor: Radboud University Medical Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Ovarian Carcinoma

Start date: 2023-03-17
Primary completion: 2026-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.